Carlo Resteghini

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

Laura D. Locati, Federica Perrone, Barbara Cortelazzi et al. · European Journal of Cancer · 2016 · 99 citations

Surgical Oncology, Medicine, Pathology +8

Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life

Laura D. Locati, Donata Galbiati, Giuseppina Calareso et al. · Cancer · 2020 · 85 citations

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

Paolo Bossi, Cristiana Bergamini, Rosalba Miceli et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 69 citations

Salivary Cytokine Levels, Radiation Therapy, Medicine +12

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

Cristiana Bergamini, Laura D. Locati, Paolo Bossi et al. · Oral Oncology · 2016 · 63 citations

Nursing, Primary Care, Surgical Oncology +12

A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy

Elisa Maria Zini, Giordano Lanzola, Silvana Quaglini et al. · International Journal of Medical Informatics · 2019 · 46 citations

Oncology, Assistive Technology, Health Sciences +13